Genotyping technology: the present and the future

Abstract

Genotyping technologies for single nucleotide polymorphisms (SNPs) have matured greatly in recent years. Although a universal method that meets all genotyping needs does not exist, many innovative, robust, high‐throughput, and cost‐effective approaches have been developed. The enormous interest in using SNPs as markers for mapping complex disease genes, and their other applications in diagnostics and pharmacogenomics will continue to drive the improvement of genotyping methods. In this article, we discuss several directions being taken for further development of genotyping technologies.